Page last updated: 2024-10-17

2-aminoadipic acid and Shock, Septic

2-aminoadipic acid has been researched along with Shock, Septic in 1 studies

2-Aminoadipic Acid: A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; (NMDA).
2-aminoadipic acid : An alpha-amino acid that is adipic acid bearing a single amino substituent at position 2. An intermediate in the formation of lysine.

Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.

Research Excerpts

ExcerptRelevanceReference
"l-Carnitine is a candidate therapeutic for the treatment of septic shock, a condition that carries a ≥40% mortality."2.90Untargeted Metabolomics Differentiates l-Carnitine Treated Septic Shock 1-Year Survivors and Nonsurvivors. ( Evans, CR; Jones, AE; Karnovsky, A; Michailidis, G; Puskarich, MA; Stringer, KA, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evans, CR1
Karnovsky, A1
Puskarich, MA1
Michailidis, G1
Jones, AE1
Stringer, KA1

Trials

1 trial available for 2-aminoadipic acid and Shock, Septic

ArticleYear
Untargeted Metabolomics Differentiates l-Carnitine Treated Septic Shock 1-Year Survivors and Nonsurvivors.
    Journal of proteome research, 2019, 05-03, Volume: 18, Issue:5

    Topics: 2-Aminoadipic Acid; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Carnitine; Chr

2019